DON LYNN GIBBONS to Fusion Proteins, bcr-abl
This is a "connection" page, showing publications DON LYNN GIBBONS has written about Fusion Proteins, bcr-abl.
Connection Strength
0.657
-
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy. Proc Natl Acad Sci U S A. 2014 Mar 04; 111(9):3550-5.
Score: 0.306
-
The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm. Cancer. 2012 Jan 15; 118(2):293-9.
Score: 0.255
-
Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments. Mol Oncol. 2013 Oct; 7(5):968-75.
Score: 0.073
-
ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block. Oncogene. 1996 Nov 21; 13(10):2225-34.
Score: 0.023